• 1
    Stone NN, Stock RG. Long term urinary, sexual, and rectal morbidity in patients treated with I-125 prostate brachytherapy followed up for minimum of 5 years. Urology 2007; 69: 33842
  • 2
    Merrick GS, Butler WM, Wallner KE. Erectile function after prostate brachytherapy. Int J Radiation Oncol Biol Phys 2005; 62: 43747
  • 3
    Zelefsky MJ, Hollister T, Raben A. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate cancer implantation for patients with localized prostate cancer. Int J Radiation Oncol Biol Phys 2000; 47: 12616
  • 4
    Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001; 165: 4369
  • 5
    Talcott JA, Clark JA, Stark PC. Long term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001; 166: 4949
  • 6
    Potters L, Torre T, Fearn PA. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiation Oncol Biol Phys 2001; 50: 123542
  • 7
    Sanda MG, Dunn RL, Michalski J. Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med 2008; 358: 125061
  • 8
    Merrick GS, Butler WM, Lief JH. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urology 1999; 53: 11126
  • 9
    Ohebshalom M, Parker M, Guhring P. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations. J Urol 2005; 174: 25862
  • 10
    Padma-Nathan H, McCullough AR, Giuliano F. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 4 (Suppl.): abstract 1402
  • 11
    Gallo L, Perdona S, Autorino R. Recovery of erection after pelvic urologic surgery: our experience. Int J Impot Res 2005; 17: 484
  • 12
    Grimm PD, Blasko JC, Sylsvester JE. 10 year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy. Int J Radiation Oncol Biol Phys 2001; 51: 3140
  • 13
    Lawton CA, DeSilvio M, Lee WR. Results of a phase2 trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate. Int J Radiation Oncol Biol Phys 2007; 67: 3947
  • 14
    Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171: 7714
  • 15
    Raina R, Agarwal A, Nandipati KC, Zippe CD. Interim analysis of the early use of MUSE following radical prostatectomy (RP) to facilitate early sexual activity and return of spontaneous erectile function. J Urol 2005; 173 (Suppl.): abstract 737
  • 16
    Raina R, Agarwal A, Ausmundson S, Montague DK, Zippe CD. Early use of vacuum constriction device (VCD) following radical prostatectomy (RP) facilitates early sexual activity and potential return of erection. Int J Impot Res 2006; 18: 7781
  • 17
    Raina R, Lakin MM, Agarwal A, Ausmundson S, Montague DK, Zippe CD. Long-term intracavernosal therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. Urology 2004; 63: 5327